{"id":"W4405906667","doi":"10.1182/bloodadvances.2024014865","title":"Advancing drug development in myelodysplastic syndromes","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"Genentech; U.S. Food and Drug Administration; National Institutes of Health; Paracelsus Medizinische Privatuniversität; Cincinnati Children's Hospital Medical Center; Università degli Studi di Firenze; National Heart, Lung, and Blood Institute; Acceleron; Eli Lilly and Company; Universidad de Salamanca; Memorial Sloan-Kettering Cancer Center; University of Washington; Bristol-Myers Squibb; Cleveland Clinic; University of Miami; Pfizer; Northwestern University; Incyte; National Cancer Institute; Servier; Ohio State University; University of Pennsylvania; Alexion Pharmaceuticals; Massachusetts General Hospital; Sanofi; AstraZeneca; Celgene","keywords":"Myelodysplastic syndromes; Medicine; Decitabine; Drug development; Clinical trial; Oncology; Stem cell; Transplantation; Intensive care medicine; Hematopoietic stem cell transplantation; Food and drug administration; Drug; Internal medicine; Pharmacology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005428132,0.0007187886,0.002580456,0.001062506,0.00007116474,0.00005456866,0.0003925789,0.0002437638,0.0001057484],"category_scores_gemma":[0.0004062759,0.000513442,0.0003377421,0.001261048,0.000100027,0.0001913682,0.0003246165,0.001493274,0.001222753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008588138,"about_ca_system_score_gemma":0.003208395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009032591,"about_ca_topic_score_gemma":0.00006836773,"domain_scores_codex":[0.9962634,0.0001146948,0.001089,0.0009661285,0.0006681549,0.0008985549],"domain_scores_gemma":[0.9984882,0.0004801988,0.0001901672,0.0004900199,0.00006580501,0.0002855894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001042552,0.000123615,0.00003952159,0.09560549,0.0003709641,0.003071724,0.0001294133,0.000001486441,0.000001072517,0.00005427188,0.000797271,0.8997948],"study_design_scores_gemma":[0.0005168822,0.00006075804,0.00000842704,0.07797126,0.001515113,0.001254893,0.00006621882,0.000004082431,0.0000126637,0.00003721727,0.9181062,0.0004462808],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001195628,0.995782,0.00001128676,0.00008112209,0.0004706268,0.001370834,0.00001774586,0.0001816442,0.001965226],"genre_scores_gemma":[0.0000197363,0.9857411,0.005378035,0.0000378177,0.0003016261,0.0005274999,0.00012968,0.0001655143,0.007698938],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9173089,"threshold_uncertainty_score":0.9997317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02886272746914764,"score_gpt":0.3608832563954044,"score_spread":0.3320205289262568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}